Literature DB >> 19109555

ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.

Natalie B Collins1, James B Wilson, Thomas Bush, Andrei Thomashevski, Kate J Roberts, Nigel J Jones, Gary M Kupfer.   

Abstract

Previous work has shown several proteins defective in Fanconi anemia (FA) are phosphorylated in a functionally critical manner. FANCA is phosphorylated after DNA damage and localized to chromatin, but the site and significance of this phosphorylation are unknown. Mass spectrometry of FANCA revealed one phosphopeptide, phosphorylated on serine 1449. Serine 1449 phosphorylation was induced after DNA damage but not during S phase, in contrast to other posttranslational modifications of FA proteins. Furthermore, the S1449A mutant failed to completely correct a variety of FA-associated phenotypes. The DNA damage response is coordinated by phosphorylation events initiated by apical kinases ATM (ataxia telangectasia mutated) and ATR (ATM and Rad3-related), and ATR is essential for proper FA pathway function. Serine 1449 is in a consensus ATM/ATR site, phosphorylation in vivo is dependent on ATR, and ATR phosphorylated FANCA on serine 1449 in vitro. Phosphorylation of FANCA on serine 1449 is a DNA damage-specific event that is downstream of ATR and is functionally important in the FA pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109555      PMCID: PMC2652366          DOI: 10.1182/blood-2008-05-154294

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

2.  DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links.

Authors:  Y M Akkari; R L Bateman; C A Reifsteck; S B Olson; M Grompe
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.

Authors:  H Yagasaki; D Adachi; T Oda; I Garcia-Higuera; N Tetteh; A D D'Andrea; M Futaki; S Asano; T Yamashita
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

5.  Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.

Authors:  F Qiao; A Moss; G M Kupfer
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

6.  An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Authors:  J R Jackson; A Gilmartin; C Imburgia; J D Winkler; L A Marshall; A Roshak
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

Review 7.  The emerging genetic and molecular basis of Fanconi anaemia.

Authors:  H Joenje; K J Patel
Journal:  Nat Rev Genet       Date:  2001-06       Impact factor: 53.242

8.  ATR-dependent phosphorylation of ATRIP in response to genotoxic stress.

Authors:  Eisuke Itakura; Kazuyuki Umeda; Ei Sekoguchi; Hideki Takata; Mariko Ohsumi; Akira Matsuura
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

9.  Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.

Authors:  Toshiyasu Taniguchi; Irene Garcia-Higuera; Bo Xu; Paul R Andreassen; Richard C Gregory; Seong-Tae Kim; William S Lane; Michael B Kastan; Alan D D'Andrea
Journal:  Cell       Date:  2002-05-17       Impact factor: 41.582

10.  FANCG is phosphorylated at serines 383 and 387 during mitosis.

Authors:  Jun Mi; Fengyu Qiao; James B Wilson; Anthony A High; Melanie J Schroeder; Peter T Stukenberg; Amy Moss; Jeffrey Shabanowitz; Donald F Hunt; Nigel J Jones; Gary M Kupfer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more
  48 in total

1.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Authors:  Maria Castella; Roser Pujol; Elsa Callén; Juan P Trujillo; José A Casado; Hans Gille; Francis P Lach; Arleen D Auerbach; Detlev Schindler; Javier Benítez; Beatriz Porto; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Luis Madero; Elena Cela; Cristina Beléndez; Cristina Díaz de Heredia; Teresa Olivé; José Sánchez de Toledo; Isabel Badell; Montserrat Torrent; Jesús Estella; Angeles Dasí; Antonia Rodríguez-Villa; Pedro Gómez; José Barbot; María Tapia; Antonio Molinés; Angela Figuera; Juan A Bueren; Jordi Surrallés
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

2.  Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.

Authors:  Seok-Won Jang; Jin Ki Jung; Jung Min Kim
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

Review 3.  Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.

Authors:  Ronald S Cheung; Toshiyasu Taniguchi
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI.

Authors:  Stacy A Williams; Simonne Longerich; Patrick Sung; Cyrus Vaziri; Gary M Kupfer
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

Review 6.  The BLM dissolvasome in DNA replication and repair.

Authors:  Kelly A Manthei; James L Keck
Journal:  Cell Mol Life Sci       Date:  2013-03-31       Impact factor: 9.261

7.  The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.

Authors:  Xiaoyong Chen; James B Wilson; Patricia McChesney; Stacy A Williams; Youngho Kwon; Simonne Longerich; Andrew S Marriott; Patrick Sung; Nigel J Jones; Gary M Kupfer
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

8.  Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Authors:  Philip S Rudland; Angela M Platt-Higgins; Lowri M Davies; Suzete de Silva Rudland; James B Wilson; Abdulaziz Aladwani; John H R Winstanley; Dong L Barraclough; Roger Barraclough; Christopher R West; Nigel J Jones
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

Review 9.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

Review 10.  The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Authors:  Lindsey E Romick-Rosendale; Vivian W Y Lui; Jennifer R Grandis; Susanne I Wells
Journal:  Mutat Res       Date:  2013-01-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.